Amicus Therapeutics, Inc. earnings per share and revenue

FOLD earnings per share for the last quarter are -0.02 USD whereas the estimation was 0.00 USD which accounts for -1792.05% surprise. Company revenue for the same period amounts to 141.52 M USD despite the estimated figure of 134.93 M USD. Estimated earnings per share for the next quarter are 0.02 USD, and revenue is expected to reach 146.25 M USD. Also watch annual changes over time to get a bigger picture of FOLD earnings per share and revenue dynamics.